Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.verified

6617.TWO

Price:

$85

Market Cap:

$10.42B

Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of liver cancer; PTS-02 for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company was founded in 2014 and is based in Taipei, Taiwan.

Industry

Medical - Distribution

IPO Date

2017-02-08

Stock Exchange

TWO

Ticker

6617.TWO

The Enterprise Value as of December 2025 (TTM) for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) is 9.53B

According to Gongwin Biopharm Holdings Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.53B. This represents a change of -18.83% compared to the average of 11.74B of the last 4 quarters.

Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) Historical Enterprise Value (quarterly & annually)

How has 6617.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Gongwin Biopharm Holdings Co., Ltd. over the last ten years is 21.74B. The current 9.53B Enterprise Value has changed 4.28% with respect to the historical average. Over the past ten years (40 quarters), 6617.TWO's Enterprise Value was at its highest in in the March 2023 quarter at 36.12B. The Enterprise Value was at its lowest in in the June 2025 quarter at 10.56B.

Quarterly (TTM)
Annual

Average

21.74B

Median

22.52B

Minimum

7.96B

Maximum

34.09B

Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gongwin Biopharm Holdings Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 207.96%

Maximum Annual Enterprise Value = 34.09B

Minimum Annual Increase = -39.74%

Minimum Annual Enterprise Value = 7.96B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202412.94B-36.99%
202320.54B-39.74%
202234.09B12.16%
202130.39B24.02%
202024.51B207.96%

Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) Average Enterprise Value

How has 6617.TWO Enterprise Value performed in the past?

The current Enterprise Value of Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

22.52B

5-year avg

24.49B

10-year avg

21.74B

Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) Enterprise Value vs. Peers

How is 6617.TWO’s Enterprise Value compared to its peers?

Gongwin Biopharm Holdings Co., Ltd.’s Enterprise Value is less than Taiwan Navigation Co., Ltd. (18.94B), greater than Kedge Construction Co., Ltd. (6.79B), less than Horng Terng (14.71B), less than Taiwan Steel Union Co., Ltd (11.74B), less than TURVO International Co., Ltd. (11.91B), less than Rechi Precision Co., Ltd. (15.08B), greater than Dimerco Express Corporation (7.61B), less than Mirle Automation Corporation (13.82B), less than Phihong Technology Co., Ltd. (11.13B), less than Chinese Maritime Transport Ltd. (19.59B),

Build a custom stock screener for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gongwin Biopharm Holdings Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gongwin Biopharm Holdings Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Gongwin Biopharm Holdings Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)?

What is the 3-year average Enterprise Value for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)?

What is the 5-year average Enterprise Value for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)?

How does the current Enterprise Value for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) compare to its historical average?